Noticias Sonnet BioTherapeutics Holdings Inc - SONN | Acciones NASDAQ | ADVFN

US Dollar vs MXN

Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

Regístrate

Inicio
Invertir
Acciones
Estados Unidos
NASDAQ
Sonnet BioTherapeutics Holdings Inc (SONN)
Sonnet BioTherapeutics Holdings Inc (SONN) Noticias

Sonnet BioTherapeutics Holdings Inc (SONN)

2.67

-0.10

( -3.61% )

Actualizado: 13:54:34

Delayed by 15 minutes

Herramientas de nivel profesional para inversores individuales.

Form S-8 - Securities to be offered to employees in employee benefit plans

Sonnet BioTherapeutics Releases Virtual Investor ‘”What this Means” Segment

Drs. Pankaj Mohan, CEO of Sonnet, and John Cini, CSO of Sonnet, discuss the Company’s recent issuance of a U.S...

Form 8-K - Current report

Form 424B4 - Prospectus [Rule 424(b)(4)]

Form EFFECT - Notice of Effectiveness

Sonnet BioTherapeutics Announces Pricing of $5.0 Million Underwritten Public Offering Priced At-The-Market Under Nasdaq Rules

PRINCETON, NJ, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (the "Company" or...

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

Form 8-K - Current report

Sonnet BioTherapeutics Announces Issuance of U.S. Patent Covering a Variant IL-18 Incorporated into Two Novel Immunotherapeutic Drug Candidates

Both novel bifunctional (SON-1411) and monofunctional (SON-1400) fusion proteins exhibit wild-type binding to...

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

Form S-1 - General form for registration of securities under the Securities Act of 1933

Form 8-K - Current report

Sonnet BioTherapeutics Inc. Regains Compliance with Nasdaq

PRINCETON, NJ, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (the “Company” or...

Form 8-K - Current report

Sonnet BioTherapeutics Inc. Enters into Licensing Agreement with Alkem Laboratories Limited to Develop and Commercialize SON-080 for Diabetic Peripheral Neuropathy (DPN) in India

Sonnet to receive $1.0 million in upfront payment and up to an additional$1.0 million in milestone payments...

tw0122

tw0122 3 semanas hace

Reverse split was September

Invest-in-America

Invest-in-America 3 semanas hace

SONN: They announced a DUMP-to-Market routine!!! (The WORST thing any firm could do when their stock is SOARING!!!! WOW!!!!)

Tiger Money

Tiger Money 3 semanas hace

What is going on here? Reverse? Where is the float on this train wreck now?

bigfart

bigfart 3 semanas hace

So insiders can dump before the RS

tw0122

tw0122 3 semanas hace

Reverse split offering and now some news $8s

tw0122

tw0122 2 meses hace

May the reverse split gods come soon. Keep an eye!

BooDog

BooDog 2 meses hace

Another split here too.

https://www.globenewswire.com/news-release/2024/09/25/2952951/0/en/Sonnet-BioTherapeutics-Announces-1-for-8-Reverse-Stock-Split.html

Clemdane

Clemdane 3 meses hace

Big jump today!

Awl416

Awl416 3 meses hace

Sonnet BioTherapeutics Enters into Clinical Collaboration Agreement to Commence Investigator-Initiated and Funded Phase 1/2a Study of SON-1210 in Combination with Chemotherapy for the Treatment of Pancreatic Cancer

Monksdream

Monksdream 3 meses hace

SONN new 52=low

Clemdane

Clemdane 3 meses hace

Big jump back up today. It's a very "risk on" stock so when the market is scared, everyone dumps it.

Monksdream

Monksdream 3 meses hace

SONN new 52 week low

Monksdream

Monksdream 4 meses hace

SONN new 52 week low

Monksdream

Monksdream 5 meses hace

SONN new 52 week low

Monksdream

Monksdream 5 meses hace

SONN new 52 week low

BooDog

BooDog 7 meses hace

I see 76 followers here. And I have a target price of around 1.50 for support.

GL.

I do own shares and am looking for this to have a good future.

maq1214

maq1214 8 meses hace

Something must be happening behind closed doors. This stock has been ridiculously quite since the RS. Glad it’s greening again !

81vette

81vette 8 meses hace

23,198 watchers now,word is spreading like wildfire,somebody with lots of followers must be promoting this

81vette

81vette 8 meses hace

They are rare,not 1 in a million lotto rare but only a few per year maybe happen,the chart is great,how many bio pharma are bullish for 5 months straight (1 in a million lol) has accumulated also and that is very promising

maq1214

maq1214 8 meses hace

Do you think we are likely to see a merger/ partnership? I;m really hoping the reverse split last year cost me a lot

81vette

81vette 8 meses hace

$2.23 is 5 month high,next res. $5 mental,$7.57(sma200),big gaps to fill,mental 10/15/20/25 ect. lots of blue sky past 7.57,any kind of merger/buyout news could send it,thats the hype/hope/pump talk right now

81vette

81vette 8 meses hace

254k short,could squeeze with ZERO BORROW,73% fee(no rebate),5 months of accumulation= in the know are loading

81vette

81vette 8 meses hace

5 month uptrend(since r/s)accumulation,zero borrow,moving today on low vol(up13%),clinical trials different stages,float 2.78m,o/s 3m

BooDog

BooDog 9 meses hace

Riding free again.

Monksdream

Monksdream 9 meses hace

crowin

crowin 9 meses hace

Chardan Capital Maintains Buy on Sonnet BioTherapeutics, Lowers Price Target to $30

maq1214

maq1214 9 meses hace

This should get exciting soon, crazy volume yesterday !

BooDog

BooDog 10 meses hace

IS it just greed or might this make good for another round trip? We'll see next week.

BooDog

BooDog 11 meses hace

Good move IMO. Surprising actually.

On December 27, 2023, the Compensation Committee (the “Committee”) of the Board of Directors of Sonnet BioTherapeutics Holdings, Inc. (the “Company”) cancelled accrued but unpaid bonuses (the “Cancelled Bonuses”) that had been awarded for fiscal years 2022 and 2023 by the Committee to certain executive officers and employees of the Company. The Cancelled Bonuses total $1,930,773.10 and include (i) $631,768.12 awarded to Pankaj Mohan, Ph.D., the Company’s President and Chief Executive Officer, (ii) $312,741.79 awarded to John Cini, Ph.D, the Company’s Chief Scientific Officer and (iii) $364,504.40 awarded to Jay Cross, the Company’s Chief Financial Officer.

https://ih.advfn.com/stock-market/NASDAQ/sonnet-biotherapeutics-SONN/stock-news/92897290/form-8-k-current-report

Monksdream

Monksdream 1 año hace

SONN new 52 week low

BooDog

BooDog 1 año hace

Discount. Maybe I should have added "again". 1.60 offering and this is pushing towards the $. Very small float. Just playing the bounce. IF there is one lol.

https://www.accesswire.com/viewarticle.aspx?id=796208

valleybenedetto

valleybenedetto 1 año hace

Absolute piece of shit co, shit stock, dilution is endless. CEO should be fired. Sell now

Monksdream

Monksdream 1 año hace

SONN new 52 week low

Monksdream

Monksdream 1 año hace

SONN new 52 week low

Monksdream

Monksdream 1 año hace

SONN new 52 week low

Monksdream

Monksdream 1 año hace

SONN new 52 week low

valleybenedetto

valleybenedetto 1 año hace

If they would stop shitting on shareholders, cut costs and actually get something accomplished that would be a start.

Monksdream

Monksdream 1 año hace

If the stock continues to make new lows on its way to a delisting to Cromwell Coulson’s stock market or a dissolution I will continue to record it

valleybenedetto

valleybenedetto 1 año hace

You worry about you ok?

Monksdream

Monksdream 1 año hace

You aren’t getting any money back
Time to move on

valleybenedetto

valleybenedetto 1 año hace

Not an Urban Myth ..I've already checked. They have current D and O insurance.

Monksdream

Monksdream 1 año hace

Oh goddamn tell me another urban myth

valleybenedetto

valleybenedetto 1 año hace

They have D and O insurance. That's where you collect from. That's directors and officers insurance if you didn't know

Monksdream

Monksdream 1 año hace

You wouldn’t get anything from a class action lawsuit
Anyone connected to professional asset management abandoned this company long ago

valleybenedetto

valleybenedetto 1 año hace

CEO is awful. Nothing but offerings and RS. No meaningful news in months. Class action suit might be in order here.

Monksdream

Monksdream 1 año hace

SONN new 52 week low

Golden Cross

Golden Cross 1 año hace

Might be a short play here now

Golden Cross

Golden Cross 1 año hace

antman

antman 1 año hace

...During his testimony, Elon Musk called short selling “a means for, in my opinion, bad people on Wall Street to steal money from small investors.”

tw0122

tw0122 1 año hace

Biotech CEOs are mostly Wall Street whores they get compensated to short there own companies as it’s much more lucrative. They take on that toxic financing do reverse splits as part of their regular routine. Take MULN CEO for example he has no scruples or morals nor does he hide his screwing over shareholders.
As far as trading you play the post reverse splits at the right time with the low float and that is where the loot is made.
Wall Street casino.

Sonnet BioTherapeutics

Gs Finance Corp Issuer C...

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones